Finance

Lists
ALXO:NASDAQ
ALX Oncology Holdings Inc
၁.၁၃ US$
+၁.၈၀%
(+၀.၀၂၀) 1D
၁.၁၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၇, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALXO...
Open
၁.၁၁ US$
High
၁.၁၅ US$
Low
၁.၁၀ US$
Mkt. cap
၁၅.၆၃ ကုဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၅.၄၉ သိန်း
52-wk high
၂.၆၆ US$
52-wk low
၁.၀၅ US$
EPS
-၁.၁၄ US$
Beta
၀.၄၇
Shares outstanding
၁၃.၈၃ ကုဋေ
No. of employees
၄၈
Open
၁.၁၁ US$
High
၁.၁၅ US$
Low
၁.၁၀ US$
Mkt. cap
၁၅.၆၃ ကုဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၅.၄၉ သိန်း
52-wk high
၂.၆၆ US$
52-wk low
၁.၀၅ US$
EPS
-၁.၁၄ US$
Beta
၀.၄၇
Shares outstanding
၁၃.၈၃ ကုဋေ
No. of employees
၄၈
News stories
From web sources and news partners
CNBC
CNBC
·
ပြီးခဲ့သည့် ၁ နာရီ
Strange market anomaly is creating a buying opportunity in the Nasdaq 100
Newswire
Newswire
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
FatPipe (NASDAQ: FATN) Refinances Existing Debt and Reduces Borrowing Costs
marketscreener.com
marketscreener.com
·
ပြီးခဲ့သည့် ၁ နာရီ
SMJ International Receives NYSE American Warning Over Delayed Disclosure of Executive Resignations
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
About ALX Oncology Holdings Inc
CEO-
Employees၄၈
Founded၂၀၁၅
HeadquartersSouth San Francisco, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to ALXO in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ALXO in the last 3 months.
Highest
Current ၁.၁၃ US$
၅.၀၀ US$ (+၃၄၂.၄၈%)
Average
၄.၃၃ US$ (+၂၈၃.၁၉%)
Lowest
၄.၀၀ US$ (+၂၅၃.၉၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
၄.၀၀ US$
+၂၅၄%
10/01/2026
Derek Archila
Wells Fargo
Buy
Maintained
၅.၀၀ US$
+၃၄၂.၅%
09/21/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
၄.၀၀ US$
+၂၅၄%
08/17/2026
Sam Slutsky
LifeSci Capital
Hold
Maintained
-
-
08/06/2026
Michael Yee
UBS
Buy
Maintained
၆.၀၀ US$
+၄၃၁%
05/12/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၁၁ US$ / -၀.၁၆ US$
+၃၂.၄၆%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၇၄ ကုဋေ
၁.၇၆ ကုဋေ
၁.၃၆ ကုဋေ
၁.၃၁ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၀၉ သန်း
၅.၃၈ သန်း
၅.၃၆ သန်း
၅.၁၃ သန်း
Operating expense
၂.၂၅ ကုဋေ
၂.၃၀ ကုဋေ
၁.၉၀ ကုဋေ
၁.၈၃ ကုဋေ
Total operating expenses
၂.၂၅ ကုဋေ
၂.၃၀ ကုဋေ
၁.၉၀ ကုဋေ
၁.၈၃ ကုဋေ
Operating income
-၂.၂၅ ကုဋေ
-၂.၃၀ ကုဋေ
-၁.၉၀ ကုဋေ
-၁.၈၃ ကုဋေ
Other non operating income
-
-
၁.၈၈ သိန်း
-
EBT including unusual items
-၂.၂၁ ကုဋေ
-၂.၂၈ ကုဋေ
-၁.၇၉ ကုဋေ
-၁.၈၀ ကုဋေ
EBT excluding unusual items
-၂.၂၁ ကုဋေ
-၂.၂၈ ကုဋေ
-၁.၇၉ ကုဋေ
-၁.၇၁ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၂၁ ကုဋေ
-၂.၂၈ ကုဋေ
-၁.၇၉ ကုဋေ
-၁.၈၀ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-
-၀.၃၇
-၀.၁၅
-၀.၁၁
Interest and investment income
၈.၀၂ သိန်း
၅.၇၃ သိန်း
၁.၁၈ သန်း
၁.၅၁ သန်း
Interest expense
-၄.၀၈ သိန်း
-၃.၈၃ သိန်း
-၃.၃၁ သိန်း
-၂.၈၅ သိန်း
Net interest expenses
၃.၉၄ သိန်း
၁.၉၀ သိန်း
၈.၅၁ သိန်း
၁.၂၂ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၂၄ ကုဋေ
-၂.၂၉ ကုဋေ
-၁.၈၈ ကုဋေ
-၁.၇၇ ကုဋေ
Gain or loss from assets sale
-
-
-
၂.၄၆ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ